Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Merges Agencourt and Cogenics into Beckman Coulter Genomics


By Julia Karow

Beckman Coulter said last week that it has combined Agencourt Bioscience and recently acquired Cogenics to form Beckman Coulter Genomics.

The new Beckman unit, which offers genomic services such as sequencing, sample prep, genotyping, gene expression, and biological efficiency and safety testing, is headquartered in Beverly, Mass., where Agencourt is located.

The company offers next-generation sequencing services on the 454 GS FLX, Applied Biosystems SOLiD, and Illumina Genome Analyzer platforms, as well as Sanger sequencing.

It also supports "all levels of regulatory compliance," including Clinical Laboratory Improvement Amendments, according to a statement from Beckman.

Beckman Coulter announced its acquisition of Cogenics from Clinical Data, which closed this spring, in April and said at the time that Cogenics would add more services, a wider geographic reach, and a CLIA-certified lab to its genomics business (see In Sequence 4/7/2009).

Cogenics had facilities in Texas, North Carolina, France, the UK, and Germany, combining former operations of Genaissance, Lark, Icoria, Genome Express, and Epidauros.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.